Sign inJoin waitlistJoin the waitlist

Hongtao Liu

Medical Director, Stem Cell Transplant and Cellular Therapy · University of Wisconsin Hospitals and Clinics

Credentials: · · · · · ·

History

Stem Cell Transplant and Cellular Therapy · University of Wisconsin Hospitals and Clinics
Present
University of Wisconsin Hospitals and Clinics
Present
University of Wisconsin Hospitals and Clinics
Present

Hematology and Medical Oncology
University of Chicago Medical Center
1996–1999
Internal Medicine
Texas Tech University Health Sciences Center at Amarillo
1993–1996
PEKING UNION MED UNIV, (PEKING UNION MEDICAL COLL), BEIJING, CHINA
1989–1993

Research

Combination strategies to maximize the benefits of cancer immunotherapy
Review · Journal of Hematology & Oncology · 2021 · 519 citations
Emerging agents and regimens for AML
Review · Journal of Hematology & Oncology · 2021 · Sole author · 240 citations
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
Haematologica · 2014 · 213 citations

Wendy Stock
34 papers
Andrew Artz
31 papers
Richard Larson
26 papers
Michael Bishop
24 papers
Richard Pope
24 papers
Justin Kline
20 papers
Olatoyosi Odenike
20 papers
Lucy Godley
17 papers
Koen van Besien
15 papers
Satyajit Kosuri
13 papers
Harris Perlman
12 papers
Michael Thirman
9 papers

Clinical trials

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
Principal investigator · Recruiting
University of Wisconsin, Madison
2026–2031
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies
Principal investigator · Terminated · Phase 1
University of Chicago
2017–2020
Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
University of Chicago
2015–2019
Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
Principal investigator · Completed · Phase 1
University of Chicago
2015–2020